CorMedix Inc
F:19KA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
CorMedix Inc
F:19KA
|
US |
|
C
|
CorMedix Inc
SWB:19KA
|
US |
|
A
|
Aegon NV
XHAM:AEND
|
NL |
|
Black Hills Corp
F:BHI
|
US |
|
N
|
NEC Corp
F:NEC1
|
JP |
|
Premia Finance SpA Societa di Mediazione Creditizia
F:81U
|
IT |
|
C
|
CenterPoint Energy Inc
XBER:HOU
|
US |
|
G
|
General Electric Co
XMUN:GCP
|
US |
Wall St Price Targets
19KA Price Targets Summary
CorMedix Inc
According to Wall Street analysts, the average 1-year price target for 19KA is 19.38 EUR with a low forecast of 16.413 EUR and a high forecast of 24.938 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 19KA's stock price target?
Price Target
19.38
EUR
According to Wall Street analysts, the average 1-year price target for 19KA is 19.38 EUR with a low forecast of 16.413 EUR and a high forecast of 24.938 EUR.
What is the Revenue forecast for CorMedix Inc?
Projected CAGR
8%
The compound annual growth rate for Revenue over the next 8 years is 8%.
What is the Gross Profit forecast for CorMedix Inc?
Projected CAGR
8%
The compound annual growth rate for Gross Profit over the next 5 years is 8%.
What is the Operating Income forecast for CorMedix Inc?
Projected CAGR
6%
The compound annual growth rate for Operating Income over the next 8 years is 6%.
What is the Pre-Tax Income forecast for CorMedix Inc?
Projected CAGR
-28%
The compound annual growth rate for Pre-Tax Income over the next 3 years is -28%.
What is the Net Income forecast for CorMedix Inc?
Projected CAGR
-36%
The compound annual growth rate for Net Income over the next 3 years is -36%.
